These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6534748)

  • 1. Serum sickness complicating intravenous streptokinase therapy in acute myocardial infarction.
    Alexopoulos D; Raine AE; Cobbe SM
    Eur Heart J; 1984 Dec; 5(12):1010-2. PubMed ID: 6534748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-sickness-like illness as a complication after streptokinase therapy for acute myocardial infarction.
    Schweitzer DH; van der Wall EE; Bosker HA; Scheffer E; Macfarlane JD
    Cardiology; 1991; 78(1):68-71. PubMed ID: 2021968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sickness and acute renal failure after streptokinase therapy for myocardial infarction.
    Davies KA; Mathieson P; Winearls CG; Rees AJ; Walport MJ
    Clin Exp Immunol; 1990 Apr; 80(1):83-8. PubMed ID: 2323103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute interstitial nephritis with severe but reversible renal failure due to streptokinase.
    van Ierland-van Leeuwen ML; Zietse R; van de Wetering J; Mulder AH; Vermeulen AM; van Toorenenbergen AW; Weimar W
    Nephrol Dial Transplant; 1994; 9(8):1182-4. PubMed ID: 7800224
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intracerebral hemorrhage and serum sickness after thrombolytic treatment in myocardial infarction].
    Kierkegaard A
    Lakartidningen; 1991 Sep; 88(38):3069-70. PubMed ID: 1921594
    [No Abstract]   [Full Text] [Related]  

  • 6. Streptokinase therapy. Recognizing and treating allergic reactions.
    Stephens MB; Pepper PV
    Postgrad Med; 1998 Mar; 103(3):89-90. PubMed ID: 9519032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute renal failure following intravenous streptokinase infusion for acute myocardial infarction.
    Birnbaum Y; Strasberg B; Rechavia E; Neuman Y; Stahl B
    West J Med; 1993 Apr; 158(4):406-9. PubMed ID: 8317134
    [No Abstract]   [Full Text] [Related]  

  • 8. [Serum sickness after fibrinolysis using intravenous streptokinase in myocardial infarction].
    Albert F; Dubourg O; Steg G; Delorme G; Bourdarias JP
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1013-5. PubMed ID: 3144250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lingual hematoma due to streptokinase in a patient with acute myocardial infarction.
    Kaya A; Ordu S; Albayrak ES; Aydin M; Erden I; Ozhan H
    Am J Emerg Med; 2010 Oct; 28(8):985.e1-2. PubMed ID: 20825845
    [No Abstract]   [Full Text] [Related]  

  • 10. Spontaneous rectus muscle hematoma following streptokinase therapy for acute myocardial infarction: a case report.
    Yilmaz MB; Akin Y; Güray U; Kisacik H; Korkmaz S
    Int J Cardiol; 2002 Jul; 84(1):101-3. PubMed ID: 12104074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum sickness and purpura following intravenous streptokinase.
    Clesham GJ; Terry HJ; Jalihal S; Toghill PJ
    J R Soc Med; 1992 Oct; 85(10):638-9. PubMed ID: 1433049
    [No Abstract]   [Full Text] [Related]  

  • 12. Does the potential for development of streptokinase antibodies change the risk-benefit ratio in older patients?
    Brügemann J; de Graeff PA; van der Meer J; Lie KI
    Drugs Aging; 1995 Aug; 7(2):110-6. PubMed ID: 7579782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allergic reaction to streptokinase].
    Toquero J; Silva L
    Rev Esp Cardiol; 2001 Oct; 54(10):1225. PubMed ID: 11591304
    [No Abstract]   [Full Text] [Related]  

  • 14. An interim report of the efficacy and safety of anisoylated plasminogen streptokinase activator complex (APSAC).
    Johnson ES; Cregeen RJ
    Drugs; 1987; 33 Suppl 3():298-311. PubMed ID: 3315612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.
    Rothbard RL; Anderson JL; Fitzpatrick PG; Hakworthy RA; Sorensen SG; Marder VJ
    Clin Cardiol; 1990 Mar; Suppl 5():V11-4; discussion V27-32. PubMed ID: 2182234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative tolerance and complications in a multicentre trial of intracoronary streptokinase and intravenous anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Rothbard RL
    Drugs; 1987; 33 Suppl 3():276-8. PubMed ID: 3315606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome after streptokinase therapy for acute myocardial infarction.
    Eshraghian A; Eshraghian H; Aghasadeghi K
    Intern Med; 2010; 49(22):2445-6. PubMed ID: 21088346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse pulmonary hemorrhage after fibrinolytic therapy for acute myocardial infarction.
    Masip J; Vecilla F; Páez J
    Int J Cardiol; 1998 Jan; 63(1):95-7. PubMed ID: 9482153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Streptokinase in acute myocardial infarction].
    Malmcrona R; Ryttberg B; Stjerna A
    Lakartidningen; 1985 Nov; 82(48):4212-4. PubMed ID: 4079605
    [No Abstract]   [Full Text] [Related]  

  • 20. Bilateral anterior uveitis: a feature of streptokinase-induced serum sickness.
    Proctor BD; Murray PG; Joondeph BC
    N Engl J Med; 1994 Feb; 330(8):576-7. PubMed ID: 8302336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.